Sign in

CIK 0001326732 · Accelerated filer

Ticker
XNCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
201622502
Phone
626-305-5900
Business address
465 N. HALSTEAD ST., SUITE 200, PASADENA, CA, 91107
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,591,617
in 2 filings

Net −$3,591,617. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-03 Eckert Celia SVP, GENERAL COUNSEL Sale −1,492 $11.90 $18K 81,929
2026-03-03 Desjarlais John R SR. VICE PRESIDENT & CSO Sale −2,663 $11.90 $32K 270,451
2026-03-03 Dahiyat Bassil I PRESIDENT & CEO Sale −6,758 $11.90 $80K 567,792
2026-03-02 Cornelissen Bart Jan SR. VICE PRESIDENT & CFO Grant or award +19,458 81,914
2026-03-02 Cornelissen Bart Jan SR. VICE PRESIDENT & CFO Grant or award · Stock Option (Right to Buy) +116,750 116,750
2026-03-02 Eckert Celia SVP, GENERAL COUNSEL Grant or award +18,680 83,421
2026-03-02 Eckert Celia SVP, GENERAL COUNSEL Grant or award · Stock Option (Right to Buy) +112,080 112,080
2026-03-02 Desjarlais John R SR. VICE PRESIDENT & CSO Grant or award +24,907 273,114
2026-03-02 Desjarlais John R SR. VICE PRESIDENT & CSO Grant or award · Stock Option (Right to Buy) +149,440 149,440
2026-03-02 Dahiyat Bassil I PRESIDENT & CEO Grant or award +97,291 574,550
2026-03-02 Dahiyat Bassil I PRESIDENT & CEO Grant or award · Stock Option (Right to Buy) +583,748 583,748
2026-01-23 Desjarlais John R SR. VICE PRESIDENT & CSO Option exercise +5,322 $12.51 $67K 248,207
2026-01-23 Desjarlais John R SR. VICE PRESIDENT & CSO Option exercise · Stock Option (Right to Buy) −5,322 0
2025-12-22 Desjarlais John R SR. VICE PRESIDENT & CSO Option exercise +6,311 $12.51 $79K 242,885
2025-12-22 Desjarlais John R SR. VICE PRESIDENT & CSO Option exercise · Stock Option (Right to Buy) −6,311 5,322
2025-12-22 Dahiyat Bassil I PRESIDENT & CEO Option exercise +10,624 $12.51 $133K 477,259
2025-12-22 Dahiyat Bassil I PRESIDENT & CEO Option exercise · Stock Option (Right to Buy) −10,624 0
2025-12-19 Desjarlais John R SR. VICE PRESIDENT & CSO Option exercise +73,367 $12.51 $918K 309,941
2025-12-19 Desjarlais John R SR. VICE PRESIDENT & CSO Sale −73,367 $15.72 $1.2M 236,574
2025-12-19 Desjarlais John R SR. VICE PRESIDENT & CSO Option exercise · Stock Option (Right to Buy) −73,367 11,633

Page 3 of 11 · 211 trades